, which directed the Oregon Health Authority to “license and regulate the manufacturing, transportation, delivery, sale and purchase of psilocybin products and the provision of psilocybin services” after a two-year development period that ends in 2022.
The report concluded with a list of 11 recommendations for the OHA. Key among them was creating an “ongoing review” of psilocybin research, considering cultivation methods in the development of regulatory framework and developing a screening process to identify any possible contaminants on the substance.Article content
Officials say they believe the recommendations will greatly benefit the health and well-being of Oregonians. “It’s a very exciting opportunity to be a part of something that can alleviate the suffering of so many people,” Andre Ourson, administrator for the Center for Health Protection, told“It’s something that we do in public health. We want to better the health of Oregonians and this measure is just another tool to do that,” Ourson said.
Even so, Mason Marks, a member of the Oregon Advisory Board for Psilocybin, urged caution. “Though the board’s first report is useful, I would recommend that regulators hold off on incorporating these findings into their policy recommendations until additional research has been completed by the board,” Marks told
TheGrowthOp Finding a new hobby also works.